For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Natriuretic Peptide Test market:
According to our latest research, the global Natriuretic Peptide Test market looks promising in the next 5 years. As of 2022, the global Natriuretic Peptide Test market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Natriuretic peptides are substances made by the heart. Two main types of these substances are brain natriuretic peptide (BNP) and N-terminal pro b-type natriuretic peptide (NT-proBNP). High levels may mean that the heart pumps insufficient blood Meet physical needs. When this happens, it is called heart failure, sometimes also called congestive heart failure.
Natriuretic peptide test is generally used to measure the level of BNP or NT-proBNP in the blood. The BNP test or NT-proBNP test is most commonly used to diagnose or rule out heart failure.
Since the spread of COVID-19, various industries across the Asia-Pacific region have gradually been affected by the epidemic.
In the short term, COVID-19 has caused Natriuretic Peptide Test corporate management efficiency to drop, commuting blocked, production plans blocked, and marketing delays. In terms of downstream demand, hospitals mainly guarantee the care of COVID-19 patients during the epidemic. In the first few months of the pandemic, as countries and patients prioritized the fight against COVID-19, procedures for diagnosing and treating cardiovascular diseases such as heart disease were reduced by nearly two-thirds. Some medical institutions have adopted remote heart failure clinic programs, such as patients who need to electronically submit their daily list of symptoms, weight, blood pressure, heart rate, and blood test results to heart failure nurses.
In the long term, as the epidemic gradually improves, prevention and control measures are gradually relaxed, and procedures for the diagnosis and treatment of cardiovascular diseases such as heart disease are gradually restored. At the same time, some researchers have found that the detection of BNP/NT-proBNP has important guiding significance for the precise treatment of COVID-19. For example, the NT-pro BNP of severely ill patients increases with the severity of the disease. Therefore, considering all these factors, the Natriuretic Peptide Test market is expected to show a growth trend in the long run, and is expected to gain appeal in the next few years.
Limitations
Currently, lack of accuracy is one of the constraints to market growth. Early diagnosis of HF is very important for initiating appropriate treatment to reduce mortality, hospitalization, and medical care costs. However, sometimes the diagnosis can be challenging because not all patients with HF exhibit typical symptoms, and not all patients with seemingly typical symptoms have HF. For example, with age and kidney failure, women may have falsely high levels of BNP and NT-proBNP. Therefore, clinical evaluation and diagnostic tools are two key aspects of accurately diagnosing HF, and the lack of accuracy will limit the development of the industry.
Aging population
At present, the aging of the population is one of the problems faced by various countries in the world. In the Asia-Pacific region, South Korea, Thailand, and Singapore have relatively high proportions of people over the age of 65. The emergence of population aging will bring some opportunities to Natriuretic Peptide Test. This is mainly because people 65 years and older are more likely to suffer from heart disease, stroke, or coronary heart disease (commonly called heart disease) and heart failure than young people. Therefore, as the age grows, regular inspections are more important for the elderly population. At the same time, with the improvement of people health awareness, the demand for Natriuretic Peptide Test among the elderly will also increase.
Company Overview:
Roche is one of the major players operating in the Natriuretic Peptide Test market, holding a share of 28.92% in 2022.
Roche
Roche, a multinational pharmaceutical R&D manufacturer headquartered in Basel, Switzerland. It was founded in 1896 and now belongs to Roche Holding Co., Ltd.
Siemens Healthineers
Siemens Healthcare aspires to be a trusted partner for global healthcare providers-they can rely on this partner to help improve clinical excellence, operational efficiency and profitability.
Segmentation Overview:
By type, NT-proBNP segment accounted for the largest share of market in 2021.
NT-proBNP
This type mainly refers to the diagnosis or elimination of heart failure and other diseases by detecting NT-proBNP. N-terminal (NT)-pro hormone BNP (NT-proBNP) is a non-active prohormone that is released from the same molecule that produces BNP. NT-proBNP is a cardiac biomarker that helps diagnose heart failure.
BNP
This type mainly refers to the diagnosis or elimination of heart failure and other diseases by detecting BNP. B-type natriuretic peptide (BNP) is a hormone produced by your heart. BNP tests, also called a B-type natriuretic peptide test, measure BNP by picograms (pg.) per milliliter (mL) or nanograms per liter.
Application Overview:
The market's largest segment by application is the segment Medical Care, with a market share of 96.07% in 2021.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Natriuretic Peptide Test market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Natriuretic Peptide Test Market Report:
Market Size Estimates: Natriuretic Peptide Test market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Natriuretic Peptide Test market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Natriuretic Peptide Test market
Segment Market Analysis: Natriuretic Peptide Test market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Natriuretic Peptide Test market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Natriuretic Peptide Test Market: Revenue and sales volume of major countries in each region
Natriuretic Peptide Test Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Natriuretic Peptide Test market in major regions.
Natriuretic Peptide Test Industry Value Chain: Natriuretic Peptide Test market raw materials & suppliers, manufacturing process, distributors, downstream customers
Natriuretic Peptide Test Industry News, Policies & Regulations
Key players in the global Natriuretic Peptide Test market are covered in Chapter 12:
Biomerieux
House Of Diagnostics
Roche
Beckman Coulter Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Abbott
Metropolis Healthcare
Thermo Fisher Scientific
In Chapter 2 and Chapter 15.1, based on types, the Natriuretic Peptide Test market from 2018 to 2028 is primarily split into:
NT-proBNP
BNP
In Chapter 3 and Chapter 15.2, based on applications, the Natriuretic Peptide Test market from 2018 to 2028 covers:
Medical Care
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Natriuretic Peptide Test market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028